Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection

19Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To comprehensively characterize the contribution of virological factors as well as interleukin 28B (IL28B) single nucleotide polymorphisms (SNPs) in determining treatment responses in pegylated-interferon plus ribavirin (PEG-IFN/RBV) therapy for chronic hepatitis C virus (HCV)-1b infection, we undertook a retrospective cohort analysis for the pretreatment dominant complete HCV open reading frame (ORF) amino acid sequence study in consecutive 103 HCV-1b Japanese patients. The dominant HCV sequences classified by the response were subjected to systematic sliding window comparison analysis to characterize response-specific viral sequences along with IL28B SNPs analyses (rs8099917). In each comparison of the patients between with and without rapid viral response (RVR), non-early viral response (nEVR), sustained virological response (SVR) or relapse, following regions were extracted as most significantly associated with the different responses respectively: NS5A aa.2224-2248(p=1.2E-07), core aa.70 (p=4E-04), NS5A aa.2340-2382(p=7.0E-08) and NS5A aa.2360-2377(p=1.1E-05). Those NS5A regions nearly coincided with the interferon sensitivity-determining region (ISDR, NS5A aa.2209-2248) and the IFN/RBV resistance-determining region (IRRDR, NS5A aa.2339-2379). In a multivariate analysis, the IL28B SNP (OR 16.8, p=0.009) and NS5A aa.2340-2382 (OR 13.8, p=0.0003) were extracted as the two most significant independent variables contributing to the final outcome. (HEPATOLOGY 2012.).

Cite

CITATION STYLE

APA

Maekawa, S., Sakamoto, M., Miura, M., Kadokura, M., Sueki, R., Komase, K., … Enomoto, N. (2012). Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection. Hepatology, 56(5), 1611–1621. https://doi.org/10.1002/hep.25826

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free